Keywords: hivid, effective, videx, patients, hiv, infection, who
HIVID AS EFFECTIVE AS VIDEX
Article | 21 March 1994
For patients with HIV infection who have not responded to treatment with Wellcome's Retrovir (zidovudine), Hoffmann-La Roche's Hivid (zalcitabine) is ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Is failure to adopt business process management putting the pharma industry at risk?
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
